FINWIRES · TerminalLIVE
FINWIRES

Sichuan Biokin Pharmaceutical Secures Commitment for Share Repurchase Loan

By

Sichuan Biokin Pharmaceutical (SHA:688506) obtained a commitment letter for a 180 million yuan, three-year loan from Bank of China (HKG:3988, SHA:601988) for its share repurchase program, according to a Saturday filing with the Shanghai bourse.

The drug company plans to repurchase between 100 million yuan and 200 million yuan of shares at 398 yuan apiece.

Related Articles